Long intergenic non-protein coding RNA 1776 (LINC01776)

Long intergenic non-protein coding RNA 1776 (LINC01776) is a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs (lncRNAs) that are autonomously transcribed, longer than 200 nucleotides, and do not overlap known protein-coding genes[1][3][5]. LincRNAs act predominantly in fine-tuning gene expression, impacting biological processes via mechanisms such as chromatin remodeling, regulation of genome architecture, RNA stabilization, and transcriptional regulation—often in a tissue- and context-specific manner[1][3][5]. While the lincRNA family includes many disease- and developmentally significant molecules, specific data linking LINC01776 to particular diseases, drug interactions, or use as a biomarker is not currently available in the provided search results. There is no evidence that LINC01776 is an established therapeutic target, nor are there drugs known to directly interact with it. No prominent disease association or role as a clinical biomarker has been described for LINC01776 specifically. The information provided regarding its biological functions is general to the lincRNA family, as LINC01776 itself remains poorly characterized in the scientific literature as of now[1][3][5].

Other names

LINC01776